CCM
BSX icon

Compass Capital Management’s Boston Scientific BSX Stock Holding History

Compass Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.7M Buy
859,530
+148,656
+21% +$8.07M 2.21% 25
2026
Q1 		$44.6M Buy
710,874
+126,806
+22% +$10.1M 2.69% 24
2025
Q4 		$55.7M Buy
+584,068
New +$57.3M 3.09% 17

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Compass Capital Management's BSX Position: Q2 2026 in Review

Compass Capital Management increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $8.07M and bringing the position to 859,530 shares worth $36.7M. The position accounts for 2.21% of the portfolio, ranked #25.

Compass Capital Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $55.7M in Q4 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Compass Capital Management held 859,530 shares of Boston Scientific worth $36.7M as of Q2 2026.
  • Compass Capital Management bought 148,656 Boston Scientific shares in Q2 2026, an estimated $8.07M.
  • Boston Scientific made up 2.21% of Compass Capital Management's portfolio in Q2 2026, its #25 holding.
  • Compass Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Compass Capital Management's Boston Scientific position peaked at $55.7M in Q4 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Compass Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.